Literature DB >> 33247497

Infectious complications in allogeneic hematopoietic cell transplant recipients: Review of transplant-related risk factors and current state of prophylaxis.

Mobil Akhmedov1.   

Abstract

Allogeneic hematopoietic cell transplantation is a complex procedure that carries a significant risk of complications. Infections are among the most common of them. Several direct factors such as neutropenia, hypogammaglobulinemia, lymphopenia, mucosal barrier injury, and graft-versus-host disease have been shown to be associated with increased infectious risk post-transplant. Apart from direct factors, there are also indirect transplant-related factors that are the primary trigger to the formers' development. The most important of them are type of preparative regimen, graft source, donor type, graft-versus-host disease prophylaxis, and graft manipulation techniques. In this review, an attempt has been made to summarize the role of the transplant-related factors in the development of infectious complications and provide evidence underlying the current concept of infectious disease prophylaxis in patients after allogeneic hematopoietic cell transplantation.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  allogeneic hematopoietic cell transplantation; infections; prophylaxis; risk factors

Year:  2020        PMID: 33247497     DOI: 10.1111/ctr.14172

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

Review 1.  Clinical Manifestations of Pulmonary Mucormycosis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A 21-Case Series Report and Literature Review.

Authors:  Jing Bao; Chunyu Liu; Yongxia Dong; Yu Xu; Zhanwei Wang; Kunkun Sun; Wen Xi; Keqiang Wang; Pihua Gong; Zhancheng Gao
Journal:  Can Respir J       Date:  2022-06-02       Impact factor: 2.130

2.  Central nervous system infection with Seoul Orthohantavirus in a child after hematopoietic stem cell transplantation: a case report.

Authors:  Enyi Liu; Shuhe Lv; Panpan Yi; Li Feng; Xiaolu Deng; Han Xia; Yajing Xu
Journal:  Virol J       Date:  2022-04-22       Impact factor: 5.913

3.  Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol).

Authors:  Michele Malagola; Alessandro Turra; Liana Signorini; Silvia Corbellini; Nicola Polverelli; Lorenzo Masina; Giovanni Del Fabro; Silvia Lorenzotti; Benedetta Fumarola; Mirko Farina; Enrico Morello; Vera Radici; Eugenia Accorsi Buttini; Federica Colnaghi; Simona Bernardi; Federica Re; Arnaldo Caruso; Francesco Castelli; Domenico Russo
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.